Work

Phase II randomized study of the safety, efficacy, metabolism, and molecular targets of erlotinib in African Americans (AA) with NSCLC.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.7569

Authors: M. A. Villalona-Calero, T. Stinchcombe, M. A. Phelps, S. L. Starrett, A. C. Papp, A. M. Ghany, W. J. Hicks, G. A. Otterson, M. A. Socinski, W. Zhao

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589333318

Cites:

Cited by: 1

Related to: 10